Co-Diagnostics, Inc. (CODX) analyst actions
Rating and price-target actions on CODX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CODX overview →
3 measured CODX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform | Press release | -2.79% | -9.16% | |
| Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization | Press release | -3.60% | -16.52% | |
| Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA | Press release | +1.63% | +12.73% |
Keep exploring
More CODX: earnings → · SEC filings → · CODX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mersana Therapeutics, Inc. (MRSN) | 251 | -0.20% | 46% |
| Soligenix, Inc. (SNGX) | 251 | -0.71% | 35% |
| argenx SE - American Depositary Shares (ARGX) | 249 | -0.02% | 48% |
| Array Technologies, Inc. (ARRY) | 249 | -0.24% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.